Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humansFabio Broglio, Peter van Koetsveld Pv, Andrea Benso, et al.
Clinical Endocrinology|October 12, 2004
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humansFabio Broglio, Cristina Gottero, Flavia Prodam, et al.
Reviews in Endocrine & Metabolic Disorders|October 7, 2020
Expected and paradoxical effects of obesity on cancer treatment responseMarco Gallo, Valerio Adinolfi, Viola Barucca, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical CarcinomaAlfredo Berruti, Salvatore Grisanti, Alina Pulzer, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2025
Reassessing the role of copeptin in emergency department admissions for hypotonic hyponatremiaAlessandro Maria Berton, Emanuele Varaldo, Marco Zavattaro, et al.
Frontiers in Endocrinology|October 22, 2021
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing ScoreMirko Parasiliti-Caprino, Fabio Bioletto, Tommaso Frigerio, et al.
European Journal of Endocrinology|April 1, 2022
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgeryMirko Parasiliti-Caprino, Fabio Bioletto, Chiara Lopez, et al.
Biomedicines|June 24, 2022
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of PheochromocytomaMirko Parasiliti-Caprino, Fabio Bioletto, Chiara Lopez, et al.
European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.
Pageof 14